Wednesday 4 December 2019

P VZV IN IMMCOMPROMISED NOT THAT SEVERE X PO ACICLOVIR?

Low complication rate in immunocompromised children with varicella‐zoster virus infections in a single centre

Aim

Recent studies focusing on morbidity and mortality rates of immunocompromised children with Varicella Zoster virus (VZV) infections are scarce. We aimed to summarise our experience.

Methods

The study was a retrospective analysis of the medical records of children, who were admitted to Hadassah‐Hebrew University Medical Centre, Jerusalem, Israel during the period of 2008‐2016. Data regarding baseline characteristics, treatment and outcome were extracted from patient's medical files.

Results

We enrolled 74 patients (43% males) with a mean age of 8 (1‐19) years. Most patients (72%) had no reported complications. Clinical outcome was favourable with 73 (99%) patients who had completely recovered and none died. Multivariable analysis identified the presence of fever (p= 0.005 and 0.02; hazard ratio (HR) 7.72 and 17.61, for total and herpes zoster groups, respectively) and prolonged interval period from clinical presentation to treatment onset (p= 0.021 and 0.025; HR 1.68 and 2.26, respectively), as associated with higher rates of complications.

Conclusion

Our results found low complication rate of VZV‐associated infections in immunocompromised children admitted to a single centre. This should encourage conducting further large multi‐centre studies evaluating management of low‐risk patients with oral acyclovir treatment.

No comments:

Post a Comment